Skip to main content
Top
Published in: Current Gastroenterology Reports 4/2012

01-08-2012 | Neuromuscular Disorders of the Gastrointestinal Tract (A Foxx-Orenstein, Section Editor)

Recent Advances in the Management of Difficult Constipation

Authors: Brian E. Lacy, John Levenick, Michael Crowell

Published in: Current Gastroenterology Reports | Issue 4/2012

Login to get access

Abstract

Constipation is a highly prevalent disorder. Some patients suffer from acute, intermittent episodes of constipation. Others, however, suffer from chronic constipation, a term that refers to those patients with symptoms of constipation for more than 6 months. In clinical practice, chronic constipation is often used interchangeably with the term functional constipation, which is currently defined using the Rome III criteria. Symptoms can be burdensome, leading to a reduction in patients’ quality of life. In addition, chronic constipation is important because it imposes a significant economic impact to the health care system. Some patients with chronic constipation have persistent symptoms despite implementing lifestyle changes and using either over-the-counter agents or prescription medications. These patients may be categorized as having difficult constipation. This report will focus on recent advances in the management of difficult constipation, and include a discussion of new and upcoming medications as well as new diagnostic tests and procedures.
Literature
1.
go back to reference Higgins PDR, Johanson JF. Epidemiology of chronic constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750–9.PubMedCrossRef Higgins PDR, Johanson JF. Epidemiology of chronic constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750–9.PubMedCrossRef
2.
go back to reference Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Am J Gastroenterol. 2012;107(1):18–25.PubMedCrossRef Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Am J Gastroenterol. 2012;107(1):18–25.PubMedCrossRef
3.
go back to reference Irvine EJ, Ferrazzi S, Pare P, et al. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986–93.PubMedCrossRef Irvine EJ, Ferrazzi S, Pare P, et al. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986–93.PubMedCrossRef
4.
go back to reference Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci. 1989;34:606–11.PubMedCrossRef Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci. 1989;34:606–11.PubMedCrossRef
5.
go back to reference Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home: definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc. 1989;37:423–9.PubMed Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home: definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc. 1989;37:423–9.PubMed
6.
go back to reference O’Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992;47:M116–21.PubMed O’Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992;47:M116–21.PubMed
7.
go back to reference Frank L, Kleinman L, Farup C, Taylor L, Miner Jr P. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34:870–7.PubMedCrossRef Frank L, Kleinman L, Farup C, Taylor L, Miner Jr P. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34:870–7.PubMedCrossRef
8.
go back to reference Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227–36.PubMedCrossRef Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227–36.PubMedCrossRef
9.
go back to reference • Sun SX, DiBonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci. 2011;56:2688–95. A nice study on the impact of constipation on quality of life and the health care system. PubMedCrossRef • Sun SX, DiBonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci. 2011;56:2688–95. A nice study on the impact of constipation on quality of life and the health care system. PubMedCrossRef
10.
go back to reference Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007;26:237–48.PubMedCrossRef Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007;26:237–48.PubMedCrossRef
11.
go back to reference Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther. 2011;33:251–60.PubMedCrossRef Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther. 2011;33:251–60.PubMedCrossRef
12.
go back to reference Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.PubMedCrossRef Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.PubMedCrossRef
13.
go back to reference Rao SSC, Kuo B, McCallum RW, et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537–44.PubMedCrossRef Rao SSC, Kuo B, McCallum RW, et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537–44.PubMedCrossRef
14.
go back to reference • Camilleri M, Thorne NK, Ringel Y, et al. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010;22:874–82. A recent study comparing the standard of care for the evaluation of colonic transit (radiopaque markers) to the new technology of a wireless motility capsule. PubMedCrossRef • Camilleri M, Thorne NK, Ringel Y, et al. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010;22:874–82. A recent study comparing the standard of care for the evaluation of colonic transit (radiopaque markers) to the new technology of a wireless motility capsule. PubMedCrossRef
15.
go back to reference • Jones MP, Post J, Crowell MD. High resolution manometry in the evaluation of anorectal disorders: a simultaneous comparison with water-perfused manometry. Am J Gastroenterol. 2007;102:850–5. The only study comparing HRAM to standard anorectal manometry. PubMedCrossRef • Jones MP, Post J, Crowell MD. High resolution manometry in the evaluation of anorectal disorders: a simultaneous comparison with water-perfused manometry. Am J Gastroenterol. 2007;102:850–5. The only study comparing HRAM to standard anorectal manometry. PubMedCrossRef
16.
go back to reference Healy JC, Halligan S, Reznek RH, et al. Dynamic MR imaging compared with evacuation proctography when evaluating anorectal configuration and pelvic floor movement. Am J Roentgenol. 1997;169:775–9. Healy JC, Halligan S, Reznek RH, et al. Dynamic MR imaging compared with evacuation proctography when evaluating anorectal configuration and pelvic floor movement. Am J Roentgenol. 1997;169:775–9.
17.
go back to reference • Reiner CS, Tutuian R, Solopova AE, et al. MR defecography in patients with dyssynergic defecation: spectrum of imaging findings and diagnostic value. Br J Radiol. 2011;84:136–44. A new study evaluating the clinical utility of MR defecography. PubMedCrossRef • Reiner CS, Tutuian R, Solopova AE, et al. MR defecography in patients with dyssynergic defecation: spectrum of imaging findings and diagnostic value. Br J Radiol. 2011;84:136–44. A new study evaluating the clinical utility of MR defecography. PubMedCrossRef
18.
go back to reference Flusberg M, Sahni VA, Erturk SM, Mortele KJ. Dynamic MR defecography: assessment of the usefulness of the defecation phase. Am J Roentgenol. 2011;196:W394–9.CrossRef Flusberg M, Sahni VA, Erturk SM, Mortele KJ. Dynamic MR defecography: assessment of the usefulness of the defecation phase. Am J Roentgenol. 2011;196:W394–9.CrossRef
19.
go back to reference Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. New Eng J Med. 2008;358:2344–54.PubMedCrossRef Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. New Eng J Med. 2008;358:2344–54.PubMedCrossRef
20.
go back to reference Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut. 2009;58:357–65.PubMedCrossRef Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut. 2009;58:357–65.PubMedCrossRef
21.
go back to reference • Quigley EMM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29:315–28. One of the 3 large studies evaluating the efficacy and safety of prucalopride. PubMedCrossRef • Quigley EMM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29:315–28. One of the 3 large studies evaluating the efficacy and safety of prucalopride. PubMedCrossRef
22.
go back to reference •• Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for GI disorders. Aliment Pharmacol Ther. 2012; In press. A comprehensive review of the cardiovascular safety profile of 5-HT 4 agonists. •• Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for GI disorders. Aliment Pharmacol Ther. 2012; In press. A comprehensive review of the cardiovascular safety profile of 5-HT 4 agonists.
23.
go back to reference Eutamene H, Bradesi S, Larauche M, et al. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil. 2010;22:312–e84.PubMedCrossRef Eutamene H, Bradesi S, Larauche M, et al. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil. 2010;22:312–e84.PubMedCrossRef
24.
go back to reference Johnston JM, Kurtz CB, Drossman DA, et al. Pilot study of the effect of linaclotide in patients with chronic constipation. Am J Gastroenterol. 2009;104:125–32.PubMedCrossRef Johnston JM, Kurtz CB, Drossman DA, et al. Pilot study of the effect of linaclotide in patients with chronic constipation. Am J Gastroenterol. 2009;104:125–32.PubMedCrossRef
25.
go back to reference Lembo AJ, Kurtz CB, MacDougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010;138:886–95.PubMedCrossRef Lembo AJ, Kurtz CB, MacDougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010;138:886–95.PubMedCrossRef
26.
go back to reference •• Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. New Eng J Med. 2011;365:527–36. Two large well-designed studies demonstrating the safety and efficacy of linaclotide in the treatment of chronic constipation. PubMedCrossRef •• Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. New Eng J Med. 2011;365:527–36. Two large well-designed studies demonstrating the safety and efficacy of linaclotide in the treatment of chronic constipation. PubMedCrossRef
27.
go back to reference Simren M, Bajor A, Gillberg P-G, et al. Randomized clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation—a double-blind study. Aliment Pharmacol Ther. 2011;34:41–50.PubMedCrossRef Simren M, Bajor A, Gillberg P-G, et al. Randomized clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation—a double-blind study. Aliment Pharmacol Ther. 2011;34:41–50.PubMedCrossRef
28.
go back to reference Wong BS, Camilleri M, McKinzie S, et al. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011;106:2154–63.PubMedCrossRef Wong BS, Camilleri M, McKinzie S, et al. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011;106:2154–63.PubMedCrossRef
29.
go back to reference Hughes SF, Scott SM, Pilot MA, Williams NS. Electrically stimulated colonic reservoir for total anorectal reconstruction. Br J Surg. 1995;82:1321–6.PubMedCrossRef Hughes SF, Scott SM, Pilot MA, Williams NS. Electrically stimulated colonic reservoir for total anorectal reconstruction. Br J Surg. 1995;82:1321–6.PubMedCrossRef
30.
go back to reference Dinning PG, Fuentealba SE, Kennedy ML, et al. Sacral nerve stimulation induces pan-colonic propagating pressure waves and increases defecation frequency in patients with slow-transit constipation. Color Dis. 2006;9:123–32.CrossRef Dinning PG, Fuentealba SE, Kennedy ML, et al. Sacral nerve stimulation induces pan-colonic propagating pressure waves and increases defecation frequency in patients with slow-transit constipation. Color Dis. 2006;9:123–32.CrossRef
31.
go back to reference Kamm MA, Dudding TC, Melenhorst J, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010;59:333–40.PubMedCrossRef Kamm MA, Dudding TC, Melenhorst J, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010;59:333–40.PubMedCrossRef
32.
go back to reference • Govaert B, Maeda Y, Alberga J, et al. Medium-term outcome of sacral nerve modulation for constipation. Dis Colon Rectum. 2012;55:26–31. A just-published study showing that sacral nerve modulation may be effective in some patients with difficult constipation, however, further studies are required. PubMedCrossRef • Govaert B, Maeda Y, Alberga J, et al. Medium-term outcome of sacral nerve modulation for constipation. Dis Colon Rectum. 2012;55:26–31. A just-published study showing that sacral nerve modulation may be effective in some patients with difficult constipation, however, further studies are required. PubMedCrossRef
Metadata
Title
Recent Advances in the Management of Difficult Constipation
Authors
Brian E. Lacy
John Levenick
Michael Crowell
Publication date
01-08-2012
Publisher
Current Science Inc.
Published in
Current Gastroenterology Reports / Issue 4/2012
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-012-0269-1

Other articles of this Issue 4/2012

Current Gastroenterology Reports 4/2012 Go to the issue

Neuromuscular Disorders of the Gastrointestinal Tract (A Foxx-Orenstein, Section Editor)

When is Irritable Bowel Syndrome Not Irritable Bowel Syndrome? Diagnosis and Treatment of Chronic Functional Abdominal Pain

Neuromuscular Disorders of the Gastrointestinal Tract (A Foxx-Orenstein, Section Editor)

Meditation over Medication for Irritable Bowel Syndrome? On Exercise and Alternative Treatments for Irritable Bowel Syndrome

Gastrointestinal Infections (W Coyle, Section Editor)

Probiotics for the Treatment of Inflammatory Bowel Disease

Neuromuscular Disorders of the Gastrointestinal Tract (A Foxx-Orenstein, Section Editor)

Prokinetics in Diabetic Gastroparesis

Gastrointestinal Infections (W Coyle, Section Editor)

Cytomegalovirus Infection and the Gastrointestinal Tract

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.